BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34169371)

  • 21. The application of transanal total mesorectal excision for patients with middle and low rectal cancer: A systematic review and meta-analysis.
    Hu D; Jin P; Hu L; Liu W; Zhang W; Guo T; Yang X
    Medicine (Baltimore); 2018 Jul; 97(28):e11410. PubMed ID: 29995787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total mesorectal excision for low and middle rectal cancer: laparoscopic versus transanal approach-a meta-analysis.
    Aubert M; Mege D; Panis Y
    Surg Endosc; 2020 Sep; 34(9):3908-3919. PubMed ID: 31617090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of laparoscopic versus robot-assisted versus transanal total mesorectal excision surgery for rectal cancer: a retrospective propensity score-matched cohort study of short-term outcomes.
    Hol JC; Burghgraef TA; Rutgers MLW; Crolla RMPH; van Geloven NAW; Hompes R; Leijtens JWA; Polat F; Pronk A; Smits AB; Tuynman JB; Verdaasdonk EGG; Consten ECJ; Sietses C
    Br J Surg; 2021 Nov; 108(11):1380-1387. PubMed ID: 34370834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transanal total mesorectal excision outcomes for advanced rectal cancer in a complex surgical population.
    Gardner IH; Kelley KA; Abdelmoaty WF; Sharata A; Hayman AV; Whiteford MH
    Surg Endosc; 2022 Jan; 36(1):167-175. PubMed ID: 33416990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Robotic total mesorectal excision or transanal total mesorectal excision meta-analysis.
    Chen MZ; Tay YK; Warrier SK; Heriot AG; Kong JC
    ANZ J Surg; 2021 Nov; 91(11):2269-2276. PubMed ID: 34553466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transanal versus conventional total mesorectal excision for rectal cancer using the IDEAL framework for implementation.
    Robertson RL; Karimuddin A; Phang T; Raval M; Brown C
    BJS Open; 2021 Mar; 5(2):. PubMed ID: 33889949
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does previous transanal excision for early rectal cancer impair surgical outcomes and pathologic findings of completion total mesorectal excision? Results of a systematic review of the literature.
    Eid Y; Alves A; Lubrano J; Menahem B
    J Visc Surg; 2018 Dec; 155(6):445-452. PubMed ID: 29657063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond transanal total mesorectal excision: short-term outcomes of transanal total mesorectal excision in locally advanced rectal cancer requiring resection beyond total mesorectal excision.
    Larach JT; Rajkomar AKS; Smart PJ; McCormick JJ; Heriot AG; Warrier SK
    Colorectal Dis; 2021 Apr; 23(4):823-833. PubMed ID: 33217140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve.
    D'Andrea AP; McLemore EC; Bonaccorso A; Cuevas JM; Basam M; Tsay AT; Bhasin D; Attaluri V; Sylla P
    Surg Endosc; 2020 Sep; 34(9):4101-4109. PubMed ID: 31602515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current status of transanal total mesorectal excision for rectal cancer and the expanding indications of the transanal approach for extended pelvic surgeries.
    Uehara K; Ogura A; Murata Y; Sando M; Mukai T; Aiba T; Yamamura T; Nakamura M
    Dig Endosc; 2023 Jan; 35(2):243-254. PubMed ID: 36342054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technological Advances in the Surgical Treatment of Colorectal Cancer.
    Hahn SJ; Sylla P
    Surg Oncol Clin N Am; 2022 Apr; 31(2):183-218. PubMed ID: 35351273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transanal versus laparoscopic total mesorectal excision: a comparative study of long-term oncological outcomes.
    Ourô S; Ferreira M; Roquete P; Maio R
    Tech Coloproctol; 2022 Apr; 26(4):279-290. PubMed ID: 35050434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of pathological outcomes after transanal versus laparoscopic total mesorectal excision: a prospective study using data from randomized control trial.
    Zeng Z; Luo S; Chen J; Cai Y; Zhang X; Kang L
    Surg Endosc; 2020 Sep; 34(9):3956-3962. PubMed ID: 31586244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local Recurrence and Disease-Free Survival After Transanal Total Mesorectal Excision: Results From the International TaTME Registry.
    Roodbeen SX; Penna M; van Dieren S; Moran B; Tekkis P; Tanis PJ; Hompes R;
    J Natl Compr Canc Netw; 2021 Aug; 19(11):1232-1240. PubMed ID: 34404028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transanal total mesorectal excision (taTME) for rectal cancer: a training pathway.
    McLemore EC; Harnsberger CR; Broderick RC; Leland H; Sylla P; Coker AM; Fuchs HF; Jacobsen GR; Sandler B; Attaluri V; Tsay AT; Wexner SD; Talamini MA; Horgan S
    Surg Endosc; 2016 Sep; 30(9):4130-5. PubMed ID: 26659246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing functional outcomes between transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LaTME) for rectal cancer: a systematic review and meta-analysis.
    Choy KT; Yang TWW; Prabhakaran S; Heriot A; Kong JC; Warrier SK
    Int J Colorectal Dis; 2021 Jun; 36(6):1163-1174. PubMed ID: 33580808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Application of transanal total mesorectal excision in radical surgery for rectal cancer].
    He L; Xiao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Aug; 20(8):957-960. PubMed ID: 28836258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short Term Postoperative and Oncological Outcomes of Two-Dimensional Versus Three-Dimensional Laparoscopic Transanal Total Mesorectal Excision of Rectal Cancer.
    Tey HTV; Foo SMJ; Fong SS; Chong CS
    J Laparoendosc Adv Surg Tech A; 2020 Dec; 30(12):1350-1353. PubMed ID: 32522084
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of oncological and functional outcomes and quality of life after transanal or laparoscopic total mesorectal excision for rectal cancer: a systematic review and meta-analysis.
    Alimova I; Chernyshov S; Nagudov M; Rybakov E
    Tech Coloproctol; 2021 Aug; 25(8):901-913. PubMed ID: 34002288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oncological safety of transanal total mesorectal excision (TaTME) for rectal cancer: mid-term results of a prospective multicentre study.
    Simo V; Tejedor P; Jimenez LM; Hernan C; Zorilla J; Arrredondo J; Lapuente F; Pastor C
    Surg Endosc; 2021 Apr; 35(4):1808-1819. PubMed ID: 32333158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.